R2 Diagnostics, Inc.

R2 Diagnostics, Inc. — FDA 510(k) Submissions

R2 Diagnostics, Inc. has submitted 10 FDA 510(k) premarket notifications since 2004, of which 10 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Plasma, Coagulation Factor Deficient, Test, Time, Partial Thromboplastin, Control, Plasma, Abnormal, Test, Qualitative And Quantitative Factor Deficiency, Reagent, Russel Viper Venom . Use the specialty filter in the sidebar to narrow results.